Company · CIK 0001472012 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Immunome Inc. · IMNM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 SForm 4 → | Sep 15, 4:30 pm EDT | Jack HigginsChief Scientific Officer | 13,200 | $25.32 | $334,224 | 65,050 | −16.9% | 10b5-1 |
| Sep 11, 2026 GMForm 4 → | Sep 15, 4:30 pm EDT | Jack HigginsChief Scientific Officer | 26,800 | $1.35 | $24,300 | 56,250 | — | 10b5-1 |
| Aug 10, 2026 SForm 4 → | Aug 12, 5:47 pm EDT | Isaac BarchasDirector | 83,464 | $26.35 | $2,198,910 | 92,211 | −47.5% | 10b5-1 |
| Aug 6, 2026 SForm 4 → | Aug 10, 4:10 pm EDT | Isaac BarchasDirector | 36,088 | $26.06 | $940,453 | 72,416 | −33.3% | 10b5-1 |
| Aug 4, 2026 SForm 4 → | Aug 6, 6:30 pm EDT | Kinney HornCHIEF BUSINESS OFFICER | 90,616 | $25.09 | $2,273,555 | 0 | −100% | 10b5-1 |
| Aug 4, 2026 MForm 4 → | Aug 6, 6:30 pm EDT | Kinney HornCHIEF BUSINESS OFFICER | 90,616 | $11.89 | $1,077,379 | 90,616 | — | 10b5-1 |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Kinney HornCHIEF BUSINESS OFFICER | 31,250 | — | — | 31,250 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Philip TsaiChief Technical Officer | 38,250 | — | — | 81,550 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Sandra G. StonemanCHIEF LEGAL OFFICER & GC | 38,250 | — | — | 43,805 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Jack HigginsChief Scientific Officer | 38,250 | — | — | 60,250 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Max RosettChief Financial Officer | 47,250 | — | — | 101,287 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Robert LechleiderChief Medical Officer | 54,000 | — | — | 69,805 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Clay B SiegallPresident and CEO, Director | 180,000 | — | — | 870,704 | — | |
| Jul 7, 2026 SForm 4 → | Jul 9, 5:38 pm EDT | Kinney HornCHIEF BUSINESS OFFICER | 1,092 | $25.00 | $27,300 | 0 | −100% | 10b5-1 |
| Jul 7, 2026 MForm 4 → | Jul 9, 5:38 pm EDT | Kinney HornCHIEF BUSINESS OFFICER | 1,092 | $12.92 | $14,109 | 1,092 | — | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 7, 7:02 pm EDT | Isaac BarchasDirector | 100,000 | $24.13 | $2,412,522 | 108,504 | −48.0% | 10b5-1 |
| Jul 2, 2026 SForm 4 → | Jul 7, 5:42 pm EDT | Robert LechleiderChief Medical Officer | 55,000 | $22.62 | $1,244,331 | 15,805 | −77.7% | 10b5-1 |
| Jul 2, 2026 MForm 4 → | Jul 7, 5:42 pm EDT | Robert LechleiderChief Medical Officer | 55,000 | $8.73 | $480,150 | 70,805 | — | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 2, 8:31 pm EDT | Isaac BarchasDirector | 201,050 | $21.85 | $4,393,024 | 208,504 | −49.1% | 10b5-1 |
| Jun 25, 2026 SForm 4 → | Jun 29, 4:52 pm EDT | Robert LechleiderChief Medical Officer | 55,000 | $19.85 | $1,091,662 | 15,805 | −77.7% | 10b5-1 |
| Jun 25, 2026 MForm 4 → | Jun 29, 4:52 pm EDT | Robert LechleiderChief Medical Officer | 55,000 | $8.73 | $480,150 | 70,805 | — | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 17, 5:26 pm EDT | Max RosettChief Financial Officer | 60,000 | $18.23 | $1,093,800 | 54,037 | −52.6% | 10b5-1 |
| Jun 15, 2026 MForm 4 → | Jun 17, 5:26 pm EDT | Max RosettChief Financial Officer | 60,000 | $1.05 | $63,000 | 114,037 | — | 10b5-1 |
| Jun 5, 2026 PForm 4 → | Jun 9, 5:40 pm EDT | Jean Jacques BienaimeDirector | 10,500 | $19.45 | $204,260 | 43,415 | +31.9% | |
| Jun 5, 2026 SForm 4 → | Jun 9, 5:40 pm EDT | Jean Jacques BienaimeDirector | 10,500 | $19.41 | $203,820 | 32,915 | −24.2% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 MForm 4 → | Sep 15, 4:30 pm EDT | Jack HigginsChief Scientific Officer | 18,000 | — | — | 133,840 | — | 10b5-1 |
| Aug 4, 2026 MForm 4 → | Aug 6, 6:30 pm EDT | Kinney HornCHIEF BUSINESS OFFICER | 90,616 | — | — | 120,750 | — | 10b5-1 |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Kinney HornCHIEF BUSINESS OFFICER | 62,500 | — | — | 62,500 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Philip TsaiChief Technical Officer | 76,500 | — | — | 76,500 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Sandra G. StonemanCHIEF LEGAL OFFICER & GC | 76,500 | — | — | 76,500 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Jack HigginsChief Scientific Officer | 76,500 | — | — | 76,500 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Max RosettChief Financial Officer | 94,500 | — | — | 94,500 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Robert LechleiderChief Medical Officer | 108,000 | — | — | 108,000 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:10 pm EDT | Clay B SiegallPresident and CEO, Director | 360,000 | — | — | 360,000 | — | |
| Jul 7, 2026 MForm 4 → | Jul 9, 5:38 pm EDT | Kinney HornCHIEF BUSINESS OFFICER | 1,092 | — | — | 128,908 | — | 10b5-1 |
| Jul 2, 2026 MForm 4 → | Jul 7, 5:42 pm EDT | Robert LechleiderChief Medical Officer | 55,000 | — | — | 290,000 | — | 10b5-1 |
| Jun 25, 2026 MForm 4 → | Jun 29, 4:52 pm EDT | Robert LechleiderChief Medical Officer | 55,000 | — | — | 345,000 | — | 10b5-1 |
| Jun 15, 2026 MForm 4 → | Jun 17, 5:26 pm EDT | Max RosettChief Financial Officer | 60,000 | — | — | 0 | — | 10b5-1 |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:58 pm EDT | Sandra M SwainDirector | 9,897 | — | — | 9,897 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:56 pm EDT | Philip WagenheimDirector | 9,897 | — | — | 9,897 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:54 pm EDT | Jean Jacques BienaimeDirector | 9,897 | — | — | 9,897 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:51 pm EDT | James P BoylanDirector | 9,897 | — | — | 9,897 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:48 pm EDT | Isaac BarchasDirector | 9,897 | — | — | 9,897 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:45 pm EDT | Carol SchaferDirector | 9,897 | — | — | 9,897 | — |